Refine by
Cognitive Functions Articles & Analysis
20 news found
Are you restless during sleep at night? Do you often wake up at night due to bad dreams or have difficulty in falling asleep? Are you anxious before you sleep? There are a variety of issues that can hamper proper and restful sleep at night, apart from snoring. According to University of Arizona clinical professor of medicine and dream specialist, Rubin Naiman, PhD, the two key components of good ...
Alfa Chemistry's dietary supplement ingredients supply encompasses a wide range of products, including functional ingredients, herbs and botanical extracts, health digestion aids, and food additives. ...
In the pursuit of advancing disease research and its treatment, animal cognitive behavior is studied in a wide range of animal species. The innovative multi-type animal cognitive behavioral tests are set to complement disease research methodology, enabling scientists to gain deeper insight into the complexities of cognitive ...
It was previously investigated in a clinical Phase 2a study in Alzheimer’s disease in which blarcamesine resulted in a lower rate of both cognitive and functional ...
Altoida’s technology platform uses artificial intelligence (AI) to analyze cognitive and functional test results and help diagnose neurological diseases, like Mild Cognitive Impairment (MCI) and Alzheimer’s. The proprietary 10-minute set of digital test activities (completed on a smartphone or tablet) use augmented reality (AR) to ...
In addition, the data provided indications supporting further exploration of Lomecel-B, particularly the therapeutic potential to slow cognitive decline and improve quality of life in patients with AD. “After meeting the rigorous requirements of the VA, we are pleased to announce the addition of this particular Miami VA site to our ongoing trial,” said Geoff Green, ...
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Ariana Pharma (Cambridge, MA and Paris, France) today announced an artificial intelligence-driven, precision medicine collaboration. This collaboration is expected to identify biomarkers of response to refine patient selection to guide and accelerate the clinical development of Cyclerion’s investigational therapeutics for neurological and ...
Altoida and GN Group will research if the detection of minor changes in cognitive function and diagnosis of the condition that early, before symptoms have even begun to appear, could help physicians begin to treat at-risk patients, potentially delaying the onset or lessening the severity of the neurodegenerative disease. “Often-overlooked impairments in ...
Inflammation can contribute to the physical decline in Aging Frailty through multiple mechanisms, including detrimental effects on muscles, bone tissue, the immune system, cardiovascular function, and cognition. The necessity for identifying patients with Aging Frailty is well-acknowledged in the geriatric community, and the treatment of Aging Frailty and ...
Dementia resulting from AD is associated with vascular function decline and involves a pro-inflammatory state. In Longeveron’s prior Phase 1 trial, Lomecel-B treatment met the primary safety endpoint, with no safety concerns – including no evidence of Alzheimer’s-related imaging abnormality, known as ARIA. ...
Phase 2 TRAILBLAZER-ALZ results presented today by Eli Lilly and Company (NYSE: LLY) at the 15th International Conference on Alzheimer's & Parkinson Diseases™ 2021 (AD/PD™ 2021) held virtually March 9-14, 2021 and published simultaneously in the New England Journal of Medicine (NEJM) expand on previously reported top-line data that found donanemab met its primary endpoint and ...
The demonstration that ILB® has profound restorative effects on disrupted energy balance in the injured brain provides the foundation for future clinical trials that could reduce mortality and enhance functional recovery of people with this devastating condition”, said Co-Author Ann Logan, Scientific Director at Neuregenix and former Professor of Molecular Neuroscience ...
“A large proportion of individuals with end-stage renal disease who receive hemodialysis have cognitive impairment, which may be associated with reduced ability for self-care, poor adherence to dietary and fluid restrictions, and poor outcomes,” said Karoly Nikolich, Ph.D., chief executive officer of Alkahest. ...
Presentation Details Chair: Steven Braithwaite Session: Nanosymposium: 105 – Brain Aging and Role of Systemic Factors Date/Time: October 20, 2019, 8:00 AM Location: Room S405 Title: A transformational plasma-based approach to Alzheimer’s disease therapeutics Session: Nanosymposium: 105 – Brain Aging and Role of Systemic Factors Date/Time: October 20, 2019, 10:45-11:00 AM ...
The consequences of snoring are much more serious than an inconvenient disruption in one’s sleep pattern. In addition to the health issues and fatigue that are associated with snoring, it is now known that frequent snoring can actually cause harm to the brain. The most recent research on brain health and snoring shows the damage that can occur, and further emphasizes why it is crucial to ...
INT41 is a preclinical first-in-class Intrabody Gene Therapy that has been shown to alleviate cognitive and motor function loss in an animal model and appears to function by inhibiting gene dysregulation, also observable in human patients prior to symptom onset, caused by a mechanism described in the Webinar. ...
ByVybion
Movement, will cover all aspects of the human brain and how it functions and malfunctions. “This is our marquee event,” says Thomas Graham, Cleveland Clinic’s chief innovation officer and this year’s emcee. ...
” The 2015 ONES awardees will study substances in our environment such as arsenic, ozone, and pollution, and connections to health problems, such as cognitive function, asthma, and DNA damage. The awardees are as follows: Neelakanteswar Aluru, Ph.D., at Woods Hole Oceanographic Institution in Massachusetts, will use zebrafish models to study how ...
Research published in the Journal of Alzheimer’s Disease this week suggests healthy older adults are less capable of observing their own cognitive decline over an 18 month period than Cogstate’s computerized brief battery (CBB). The study, conducted by neuropsychologists, also indicated that close family members were unable to perceive decline in the cognitive behavior of their ...
Residents living near a busy railway line in Strasbourg were found by researchers to have reduced cognitive function compared to residents in quieter areas, which may be the result of long-term exposure to night-time noise. ...